Outlook Therapeutics, Inc. (OTLK) SEC filings
OTLK SEC filings moved a median of -0.98% by the close. OTLK SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the OTLK overview →
116 measured OTLK SEC filing events.
Where these OTLK SEC filings landedvs 116 measured OTLK SEC filing reactions
| Middle 50% of OTLK SEC filing reactions | -5.47% to +2.88% |
|---|---|
| Median reaction (to close) | -0.98% |
| Measured reactions | 116 |
Point-in-time · zero look-ahead
Half of the 116 OTLK SEC filing events with a measured close landed between -5.47% and +2.88%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Outlook Therapeutics, For: Sep 25 | SEC filing · Form 8-K | -4.21% | -0.86% | |
| Form 8-K Outlook Therapeutics, For: Sep 16 | SEC filing · Form 8-K | -3.24% | +0.15% | |
| Form 8-K Outlook Therapeutics, For: Aug 23 | SEC filing · Form 8-K | -0.20% | -0.79% | |
| Form 10-Q Outlook Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.41% | -2.50% | |
| Form NT 10-Q Outlook Therapeutics, For: Jun 30 | SEC filing · Form NT | +2.50% | +4.14% | |
| Form 8-K Outlook Therapeutics, For: Aug 12 | SEC filing · Form 8-K | -2.81% | -10.36% | |
| Form 8-K Outlook Therapeutics, For: Aug 14 | SEC filing · Form 8-K | -2.81% | -10.36% | |
| Form 8-K Outlook Therapeutics, For: Aug 12 | SEC filing · Form 8-K | +4.66% | +15.58% | |
| Form 8-K Outlook Therapeutics, For: Jul 21 | SEC filing · Form 8-K | -1.96% | +4.07% | |
| Form 8-K Outlook Therapeutics, For: Jul 24 | SEC filing · Form 8-K | -6.34% | -25.00% | |
| Form EFFECT Outlook Therapeutics, | SEC filing · Form EFFECT | -2.13% | -4.96% | |
| Form S-3 Outlook Therapeutics, | SEC filing · Form S-3 | +6.32% | -2.82% | |
| Form 8-K Outlook Therapeutics, For: Jul 16 | SEC filing · Form 8-K | -3.93% | -0.71% | |
| Form DEFA14A Outlook Therapeutics, | SEC filing · Form DEFA14A | -5.36% | -6.55% | |
| Form 8-K Outlook Therapeutics, For: Jun 26 | SEC filing · Form 8-K | +0.29% | -1.74% | |
| Form 8-K Outlook Therapeutics, For: Jun 16 | SEC filing · Form 8-K | +1.67% | +30.83% | |
| Form 8-K Outlook Therapeutics, For: Jun 01 | SEC filing · Form 8-K | -1.86% | +12.40% | |
| Form DEF 14A Outlook Therapeutics, For: Jul 16 | SEC filing · Form DEF | -8.09% | -9.60% | |
| Form DEFA14A Outlook Therapeutics, | SEC filing · Form DEFA14A | -8.09% | -9.60% | |
| Form 8-K Outlook Therapeutics, For: May 29 | SEC filing · Form 8-K | -1.86% | +12.40% | |
| Form 8-K Outlook Therapeutics, For: May 28 | SEC filing · Form 8-K | +1.33% | -2.67% | |
| Form 8-K Outlook Therapeutics, For: May 26 | SEC filing · Form 8-K | -3.48% | -13.92% | |
| Form PRE 14A Outlook Therapeutics, For: Jul 16 | SEC filing · Form PRE | -3.48% | -13.92% | |
| Form 8-K Outlook Therapeutics, For: May 15 | SEC filing · Form 8-K | -1.48% | -0.35% | |
| Form 10-Q Outlook Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.48% | -0.35% | |
| Form 8-K Outlook Therapeutics, For: May 12 | SEC filing · Form 8-K | -7.13% | -1.10% | |
| Form D Outlook Therapeutics, | SEC filing · Form D | +0.34% | +0.59% | |
| Form 8-K Outlook Therapeutics, For: Apr 22 | SEC filing · Form 8-K | -1.80% | +7.25% | |
| Form 8-K Outlook Therapeutics, For: Apr 21 | SEC filing · Form 8-K | +2.67% | +0.14% | |
| Form 8-K Outlook Therapeutics, For: Apr 07 | SEC filing · Form 8-K | -2.54% | +11.45% | |
| Form 8-K Outlook Therapeutics, For: Mar 23 | SEC filing · Form 8-K | -2.54% | +0.48% | |
| Form 8-K Outlook Therapeutics, For: Mar 13 | SEC filing · Form 8-K | -5.81% | -12.03% | |
| Form 8-K Outlook Therapeutics, For: Mar 06 | SEC filing · Form 8-K | +0.29% | +0.24% | |
| Form 8-K Outlook Therapeutics, For: Mar 10 | SEC filing · Form 8-K | +1.23% | -2.99% | |
| Form 8-K Outlook Therapeutics, For: Mar 05 | SEC filing · Form 8-K | -2.08% | -4.17% | |
| Form 8-K Outlook Therapeutics, For: Feb 18 | SEC filing · Form 8-K | -0.10% | +5.36% | |
| Form 10-Q Outlook Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | -3.87% | -3.98% | |
| Form 8-K Outlook Therapeutics, For: Feb 17 | SEC filing · Form 8-K | +0.21% | -10.30% | |
| Form 8-K Outlook Therapeutics, For: Feb 11 | SEC filing · Form 8-K | -2.79% | -8.20% | |
| Form ARS Outlook Therapeutics, For: Sep 30 | SEC filing · Form ARS | -1.49% | -2.51% | |
| Form DEF 14A Outlook Therapeutics, For: Mar 10 | SEC filing · Form DEF | -1.49% | -2.51% | |
| Form DEFA14A Outlook Therapeutics, | SEC filing · Form DEFA14A | -1.49% | -2.51% | |
| Form 8-K Outlook Therapeutics, For: Dec 31 | SEC filing · Form 8-K | -0.27% | +3.00% | |
| Form 10-K Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | -0.74% | -9.36% | |
| Form 8-K Outlook Therapeutics, For: Dec 19 | SEC filing · Form 8-K | -0.24% | -1.95% | |
| Form 8-K Outlook Therapeutics, For: Nov 03 | SEC filing · Form 8-K | -0.79% | -4.72% | |
| Form 8-K Outlook Therapeutics, For: Sep 29 | SEC filing · Form 8-K | -1.85% | -1.85% | |
| Form 8-K Outlook Therapeutics, For: Sep 05 | SEC filing · Form 8-K | +0.49% | +2.79% | |
| Form 8-K Outlook Therapeutics, For: Aug 28 | SEC filing · Form 8-K | +1.00% | -1.11% | |
| Form 10-Q Outlook Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -5.60% | -6.40% | |
| Form 8-K Outlook Therapeutics, For: Aug 14 | SEC filing · Form 8-K | -5.60% | -6.40% | |
| Form 8-K Outlook Therapeutics, For: Jun 28 | SEC filing · Form 8-K | -0.94% | +6.88% | |
| Form 8-K Outlook Therapeutics, For: Jun 02 | SEC filing · Form 8-K | -2.50% | +2.78% | |
| Form 8-K Outlook Therapeutics, For: May 22 | SEC filing · Form 8-K | -0.30% | -2.42% | |
| Form 10-Q Outlook Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.35% | +2.94% | |
| Form 8-K Outlook Therapeutics, For: May 15 | SEC filing · Form 8-K | -2.35% | +2.94% | |
| Form 8-K Outlook Therapeutics, For: Apr 09 | SEC filing · Form 8-K | +0.00% | +0.72% | |
| Form 8-K Outlook Therapeutics, For: Apr 08 | SEC filing · Form 8-K | -0.34% | +3.45% | |
| Form EFFECT Outlook Therapeutics, | SEC filing · Form EFFECT | -4.65% | -5.43% | |
| Form S-3 Outlook Therapeutics, | SEC filing · Form S-3 | +2.04% | +2.72% | |
| Form 8-K Outlook Therapeutics, For: Mar 11 | SEC filing · Form 8-K | -0.64% | -1.91% | |
| Form EFFECT Outlook Therapeutics, | SEC filing · Form EFFECT | -1.35% | -4.73% | |
| Form 8-K Outlook Therapeutics, For: Feb 28 | SEC filing · Form 8-K | -5.04% | +7.91% | |
| Form S-3 Outlook Therapeutics, | SEC filing · Form S-3 | -0.65% | -7.79% | |
| Form 10-Q Outlook Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | -3.19% | -9.04% | |
| Form 8-K Outlook Therapeutics, For: Feb 14 | SEC filing · Form 8-K | +0.53% | -0.53% | |
| Form ARS Outlook Therapeutics, For: Sep 30 | SEC filing · Form ARS | -2.12% | +0.00% | |
| Form DEF 14A Outlook Therapeutics, For: Mar 11 | SEC filing · Form DEF | -2.12% | +0.00% | |
| Form 8-K Outlook Therapeutics, For: Jan 30 | SEC filing · Form 8-K | +0.13% | -6.09% | |
| Form PRE 14A Outlook Therapeutics, For: Jan 31 | SEC filing · Form PRE | +0.13% | -6.09% | |
| Form D Outlook Therapeutics, | SEC filing · Form D | -1.29% | +1.04% | |
| Form 10-K/A Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | -0.49% | -1.49% | |
| Form 8-K Outlook Therapeutics, For: Jan 16 | SEC filing · Form 8-K | -2.73% | +1.83% | |
| Form 10-K Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | +1.49% | -5.58% | |
| Form 8-K Outlook Therapeutics, For: Dec 27 | SEC filing · Form 8-K | -2.76% | +11.05% | |
| Form 8-K Outlook Therapeutics, For: Dec 10 | SEC filing · Form 8-K | +0.72% | +2.86% | |
| Form 8-K Outlook Therapeutics, For: Dec 03 | SEC filing · Form 8-K | -3.78% | -10.27% | |
| Form 8-K Outlook Therapeutics, For: Nov 27 | SEC filing · Form 8-K | +1.70% | -3.96% | |
| Form 10-Q Outlook Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.34% | +3.09% | |
| Form 8-K Outlook Therapeutics, For: Aug 14 | SEC filing · Form 8-K | -0.25% | -7.91% | |
| Form S-8 Outlook Therapeutics, | SEC filing · Form S-8 | +0.34% | +3.09% | |
| Form 8-K Outlook Therapeutics, For: Jul 08 | SEC filing · Form 8-K | +0.14% | +6.65% | |
| Form DEF 14A Outlook Therapeutics, For: Aug 12 | SEC filing · Form DEF | -1.67% | -0.28% | |
| Form PRE 14A Outlook Therapeutics, For: Aug 12 | SEC filing · Form PRE | +0.07% | -0.26% | |
| Form 8-K Outlook Therapeutics, For: May 28 | SEC filing · Form 8-K | -1.47% | -8.59% | |
| Form 10-Q Outlook Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.66% | |
| Form 8-K Outlook Therapeutics, For: May 15 | SEC filing · Form 8-K | +0.00% | +2.66% | |
| Form 8-K Outlook Therapeutics, For: May 13 | SEC filing · Form 8-K | +1.31% | -2.89% | |
| Form EFFECT Outlook Therapeutics, | SEC filing · Form EFFECT | +0.55% | -4.65% | |
| Form 8-K Outlook Therapeutics, For: May 01 | SEC filing · Form 8-K | +2.28% | -4.71% | |
| Form S-3 Outlook Therapeutics, | SEC filing · Form S-3 | +3.03% | +8.98% | |
| Form D Outlook Therapeutics, | SEC filing · Form D | +0.90% | -3.58% | |
| Form 8-K Outlook Therapeutics, For: Apr 15 | SEC filing · Form 8-K | +1.46% | +2.46% | |
| Form 8-K Outlook Therapeutics, For: Apr 12 | SEC filing · Form 8-K | -0.58% | +1.41% | |
| Form EFFECT Outlook Therapeutics, | SEC filing · Form EFFECT | +1.30% | +1.30% | |
| Form 8-K Outlook Therapeutics, For: Apr 01 | SEC filing · Form 8-K | +2.71% | -6.75% | |
| Form EFFECT Outlook Therapeutics, | SEC filing · Form EFFECT | -7.60% | -6.10% | |
| Form D Outlook Therapeutics, | SEC filing · Form D | +1.67% | -16.99% | |
| Form S-3 Outlook Therapeutics, | SEC filing · Form S-3 | +1.67% | -16.99% | |
| Form S-8 Outlook Therapeutics, | SEC filing · Form S-8 | +1.67% | -16.99% | |
| Form 8-K Outlook Therapeutics, For: Mar 20 | SEC filing · Form 8-K | -2.78% | +0.11% | |
| Form S-3 Outlook Therapeutics, | SEC filing · Form S-3 | +3.07% | +6.63% | |
| Form 8-K Outlook Therapeutics, For: Mar 13 | SEC filing · Form 8-K | -0.95% | -2.44% | |
| Form 8-K Outlook Therapeutics, For: Mar 07 | SEC filing · Form 8-K | +0.05% | -3.59% | |
| Form 10-Q Outlook Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | +3.94% | +7.73% | |
| Form 8-K Outlook Therapeutics, For: Feb 14 | SEC filing · Form 8-K | +3.94% | +7.73% | |
| Form ARS Outlook Therapeutics, For: Sep 30 | SEC filing · Form ARS | -0.02% | +4.33% | |
| Form DEF 14A Outlook Therapeutics, For: Mar 07 | SEC filing · Form DEF | -0.02% | +4.33% | |
| Form PRE 14A Outlook Therapeutics, For: Jan 29 | SEC filing · Form PRE | -3.38% | -7.78% | |
| Form 10-K/A Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | -4.71% | -0.21% | |
| Form 8-K Outlook Therapeutics, For: Jan 22 | SEC filing · Form 8-K | -4.62% | -11.68% | |
| Form 10-K Outlook Therapeutics, For: Sep 30 | SEC filing · Form 10-K | +4.63% | +3.72% | |
| Form 8-K Outlook Therapeutics, For: Dec 22 | SEC filing · Form 8-K | +4.63% | +3.72% | |
| Form 8-K Outlook Therapeutics, For: Nov 30 | SEC filing · Form 8-K | -1.10% | -1.65% | |
| Form 8-K Outlook Therapeutics, For: Nov 02 | SEC filing · Form 8-K | +3.63% | +31.48% | |
| Form 8-K Outlook Therapeutics, For: Oct 16 | SEC filing · Form 8-K | -10.91% | +11.01% |
Keep exploring
More OTLK: earnings → · analyst actions → · OTLK overview →